Total Payments
$24,229
2021 Payments
$17.60
Companies
2
Transactions
23
Medicare Patients
4,504
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$18,980 (78.3%)
Travel$4,534 (18.7%)
Food & Beverage$524.81 (2.2%)
Education$189.99 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,780 | 4 | 48.6% |
| Honoraria | $7,200 | 2 | 29.7% |
| Travel and Lodging | $4,534 | 7 | 18.7% |
| Food and Beverage | $524.81 | 8 | 2.2% |
| Education | $189.99 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $14,280 | 17 | $0 (2021) |
| Jubilant DraxImage Inc. | $9,949 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $17.60 | 1 | Astellas Pharma US Inc ($17.60) |
| 2019 | $17.05 | 1 | Astellas Pharma US Inc ($17.05) |
| 2018 | $9,906 | 5 | Jubilant DraxImage Inc. ($9,906) |
| 2017 | $14,288 | 16 | Astellas Pharma US Inc ($14,245) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2021 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 12/06/2019 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: CARDIOLOGY | ||||||
| 09/07/2018 | Jubilant DraxImage Inc. | RUBY-FILL (Drug) | Honoraria | Cash or cash equivalent | $4,200.00 | General |
| Category: Diagnostic | ||||||
| 09/07/2018 | Jubilant DraxImage Inc. | RUBY-FILL (Drug) | Travel and Lodging | Cash or cash equivalent | $2,316.16 | General |
| Category: Diagnostic | ||||||
| 07/12/2018 | Jubilant DraxImage Inc. | RUBY-FILL (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: Diagnostic | ||||||
| 07/12/2018 | Jubilant DraxImage Inc. | RUBY-FILL (Drug) | Travel and Lodging | Cash or cash equivalent | $234.36 | General |
| Category: Dioagnostic | ||||||
| 01/08/2018 | Jubilant DraxImage Inc. | RUBY-FILL (Drug) | Food and Beverage | Cash or cash equivalent | $155.62 | General |
| Category: Diagnostic | ||||||
| 11/02/2017 | Astellas Pharma US Inc | Lexiscan (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Cardiology | ||||||
| 10/18/2017 | Astellas Pharma US Inc | Lexiscan (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: Cardiology | ||||||
| 10/17/2017 | Astellas Pharma US Inc | Lexiscan (Drug) | Food and Beverage | In-kind items and services | $120.96 | General |
| Category: Cardiology | ||||||
| 05/11/2017 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| 05/11/2017 | Astellas Pharma US Inc | — | Travel and Lodging | In-kind items and services | $64.33 | General |
| 04/18/2017 | Jubilant DraxImage Inc. | RUBY-FILL Rubidium 82 (Drug) | Food and Beverage | Cash or cash equivalent | $43.22 | General |
| Category: Diagnostic Imaging | ||||||
| 04/14/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 04/14/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $90.00 | General |
| 02/21/2017 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,340.00 | General |
| 02/21/2017 | Astellas Pharma US Inc | Lexiscan (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,240.00 | General |
| Category: Cardiology | ||||||
| 02/21/2017 | Astellas Pharma US Inc | — | Travel and Lodging | In-kind items and services | $784.40 | General |
| 02/21/2017 | Astellas Pharma US Inc | — | Travel and Lodging | In-kind items and services | $432.04 | General |
| 02/21/2017 | Astellas Pharma US Inc | — | Travel and Lodging | In-kind items and services | $423.01 | General |
| 02/21/2017 | Astellas Pharma US Inc | — | Travel and Lodging | In-kind items and services | $280.08 | General |
| 02/21/2017 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $127.03 | General |
| 02/14/2017 | Astellas Pharma US Inc | Lexiscan (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 2,438 | 3,668 | $2.8M | $807,774 |
| 2022 | 6 | 1,492 | 2,136 | $1.6M | $444,806 |
| 2021 | 5 | 301 | 550 | $449,130 | $154,969 |
| 2020 | 5 | 273 | 500 | $409,255 | $142,525 |
Total Patients
4,504
Total Services
6,854
Medicare Billing
$1.6M
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 701 | 703 | $1.2M | $428,259 | 34.9% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 305 | 612 | $612,000 | $249,610 | 40.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 304 | 1,220 | $366,000 | $53,848 | 14.7% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 646 | 648 | $372,800 | $43,618 | 11.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 303 | 305 | $122,000 | $19,166 | 15.7% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 179 | 180 | $126,000 | $13,273 | 10.5% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 559 | 559 | $780,115 | $243,776 | 31.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2022 | 161 | 322 | $322,000 | $131,856 | 40.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 161 | 644 | $193,200 | $31,128 | 16.1% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2022 | 418 | 418 | $186,600 | $25,370 | 13.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 161 | 161 | $64,400 | $10,260 | 15.9% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2022 | 32 | 32 | $22,400 | $2,418 | 10.8% |
| 78492 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2021 | 62 | 63 | $193,830 | $82,229 | 42.4% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2021 | 62 | 123 | $123,000 | $51,242 | 41.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 62 | 248 | $74,400 | $11,851 | 15.9% |
| 78434 | Nuclear medicine absolute quantification of blood flow in heart muscle | Office | 2021 | 58 | 59 | $35,100 | $5,980 | 17.0% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 57 | 57 | $22,800 | $3,667 | 16.1% |
| 78492 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2020 | 59 | 59 | $178,955 | $76,326 | 42.7% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2020 | 58 | 114 | $114,000 | $47,297 | 41.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 57 | 228 | $68,400 | $10,743 | 15.7% |
| 78434 | Nuclear medicine absolute quantification of blood flow in heart muscle | Office | 2020 | 41 | 41 | $24,700 | $4,428 | 17.9% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 58 | 58 | $23,200 | $3,731 | 16.1% |
About Dr. Howard Lewin, M.D
Dr. Howard Lewin, M.D is a Nuclear Cardiology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598780116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Lewin, M.D has received a total of $24,229 in payments from pharmaceutical and medical device companies, with $17.60 received in 2021. These payments were reported across 23 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,780).
As a Medicare-enrolled provider, Lewin has provided services to 4,504 Medicare beneficiaries, totaling 6,854 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Nuclear Cardiology, Nuclear Cardiology
- Location Los Angeles, CA
- Active Since 07/13/2006
- Last Updated 11/21/2016
- Taxonomy Code 207UN0901X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598780116
Products in Payments
- RUBY-FILL (Drug) $9,906
- Lexiscan (Drug) $4,504
- RUBY-FILL Rubidium 82 (Drug) $43.22
- LEXISCAN (Drug) $34.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.